Journal article
The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease
CJ Hendriksz, M Anheim, P Bauer, O Bonnot, A Chakrapani, JC Corvol, TJ de Koning, A Degtyareva, C Dionisi-Vici, S Doss, T Duning, P Giunti, R Iodice, T Johnston, D Kelly, HH Klünemann, S Lorenzl, A Padovani, M Pocovi, M Synofzik Show all
Current Medical Research and Opinion | TAYLOR & FRANCIS LTD | Published : 2017
Abstract
Background: Niemann-Pick disease type C (NP-C) is a rare, inherited neurodegenerative disease of impaired intracellular lipid trafficking. Clinical symptoms are highly heterogeneous, including neurological, visceral, or psychiatric manifestations. The incidence of NP-C is under-estimated due to under-recognition or misdiagnosis across a wide range of medical fields. New screening and diagnostic methods provide an opportunity to improve detection of unrecognized cases in clinical sub-populations associated with a higher risk of NP-C. Patients in these at-risk groups (“clinical niches”) have symptoms that are potentially related to NP-C, but go unrecognized due to other, more prevalent clinica..
View full abstractGrants
Funding Acknowledgements
This review was funded by Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.